Division of Orthopaedics, St Michael's Hospital and the University of Toronto, Toronto, Ontario, Canada.
J Orthop Trauma. 2010 Aug;24(8):483-90. doi: 10.1097/BOT.0b013e3181df91d9.
We sought to compare the effectiveness of an antibiotic-impregnated bioabsorbable bone substitute (BBS, tobramycin-impregnated medical-grade calcium sulfate) with antibiotic-impregnated polymethylmethacrylate (PMMA) cement beads after surgical débridement in patients with chronic nonhematogenous osteomyelitis and/or infected nonunion.
A prospective, randomized clinical trial.
A university-affiliated teaching hospital.
PATIENTS/PARTICIPANTS: Thirty patients requiring surgical treatment for chronic long bone infection or infected nonunion were included: BBS (15 patients, mean age 44.1 years) PMMA (15 patients, mean age 45.6 years).
Patients were randomized to receive either BBS or PMMA to the bone void created by surgical débridement.
Eradication of infection, new bone growth, rate of union, repeat operative procedures complications.
Patients were followed for a mean 38 months (range, 24-60 months). One patient was lost to follow-up in each group. In the BBS group, infection was eradicated in 86% (12 of 14) of patients. Seven of eight patients achieved union of their nonunion, and five patients underwent seven further surgical procedures. In the PMMA group, infection was eradicated in 86% (12 of 14) of patients. Six of eight patients achieved union of their nonunion, and nine patients required 15 further surgical procedures. There were more reoperations in the PMMA group (15 versus seven, P = 0.04), and these procedures tended to be of greater magnitude.
The results of this preliminary study suggest that, in the treatment of chronic osteomyelitis and infected nonunion, the use of an antibiotic-impregnated BBS is equivalent to standard surgical therapy in eradicating infection and that it may reduce the number of subsequent surgical procedures. A larger, definitive study on this topic is required.
我们旨在比较在慢性非血源性骨髓炎和/或感染性骨不连患者中,经外科清创术治疗后,使用抗生素浸渍的生物可吸收骨替代物(BBS,妥布霉素浸渍的医用级硫酸钙)与抗生素浸渍的聚甲基丙烯酸甲酯(PMMA)水泥珠的疗效。
前瞻性、随机临床试验。
一所大学附属医院。
患者/参与者:30 名需要手术治疗慢性长骨感染或感染性骨不连的患者入选:BBS(15 名患者,平均年龄 44.1 岁),PMMA(15 名患者,平均年龄 45.6 岁)。
患者随机接受 BBS 或 PMMA 填充外科清创术造成的骨缺损。
感染消除、新骨生长、愈合率、重复手术操作并发症。
患者平均随访 38 个月(范围 24-60 个月)。每组各有 1 名患者失访。在 BBS 组中,14 例患者中有 86%(12 例)感染得到消除。8 例非愈合患者中有 7 例实现了愈合,5 例患者进行了 7 次进一步的手术。在 PMMA 组中,14 例患者中有 86%(12 例)感染得到消除。8 例非愈合患者中有 6 例实现了愈合,9 例患者需要 15 次进一步的手术。PMMA 组的再次手术更多(15 次比 7 次,P=0.04),这些手术的范围往往更大。
这项初步研究的结果表明,在治疗慢性骨髓炎和感染性骨不连时,使用抗生素浸渍的 BBS 与标准手术治疗在消除感染方面等效,并且可能减少后续手术的次数。需要对此主题进行更大、更明确的研究。